A client with severe rheumatoid arthritis has been receiving…

A client with severe rheumatoid arthritis has been receiving anakinra therapy for several months. During a follow-up visit, the nurse reviews the client’s clinical findings and laboratory data to monitor for immunosuppressive and inflammatory complications associated with this biologic agent. Which findings should the nurse recognize as potential adverse effects related to anakinra therapy? (Select all that apply.)